Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
American journal of veterinary research    April 1, 1975   Volume 36, Issue 4 Pt.1 445-448 
Dutta SK, Shipley WD.Foals (farms 1 and 2) and mares (farms 1 and 3) vaccinated with a commercially available rhinopneumonitis vaccine were tested for the level of antibodies and for protection against the natural infection. The serum-neutralization (SN) antibody titers against equine herpesvirus type 1 were 1:8 or less in the majority of foals and 1:16 or higher in about 10%. The level of the nasal secretory antibody in the foals (farm 2) was less than 1:4. The vaccinated foals did not show any apparent respiratory tract infection for about 6 months and then an epizootic of respiratory tract disease appeared on f...
Evaluation in donkeys on an inactivated Venezuelan equine encephalitis vaccine.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    March 1, 1975   Volume 22, Issue 2 162-168 doi: 10.1111/j.1439-0450.1975.tb00576.x
Villasmil DP, De Siger J, Barrientos MP, Mussgay M, Mackenzie RB. Summary Seven donkeys were immunized with a Venezuelan equine encephalitis virus vaccine which had been prepared by inactivation of the virus with formalin and Tween-80-Tri(n-butyl)phosphate and addition of saponin. Fourteen days later they, and four non-vaccinated controls, each received 50,000 suckling mouse intraperitoneal LD50 units of challenge virus. None of the seven immunized donkeys demonstrated signs of clinical illness or viremia. Of the four non-vaccinated controls, all became ill and one died. These results suggest that more extensive experiments might well be carried out on ...
[Contribution to the antigenic study of influenza viruses in animals. II.–Antibodies, antineuraminidase in horse: conditions of apparition and importance (author’s transl)].
Annales de recherches veterinaires. Annals of veterinary research    January 1, 1975   Volume 6, Issue 4 411-420 
Fontaine M, Fontaine M.In the first part of this paper the conditions for a specific titration of antibodies against the neuraminidase (N) of each of the two horse virus subtypes are defined. The antigens used are: the H72Neq 1 recombining agent to measure the anti Neq1 antibodies and the A/Duck/Ukraine/63 strain for the anti Neq2 antibodies. The immunity response to neuraminidase appears after the natural disease; this response is studied in two foci, one due to a virus belonging to the A equi I subtype (Loire 73 strain), the other to a virus of the A equi 2 subtype (SHN 73 strain). The kinetics of apparition of an...
Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis.
Journal of the American Veterinary Medical Association    October 1, 1974   Volume 165, Issue 7 621-625 
Jochim MM, Barber TL.No abstract available
Recall of immunity in horses previously immunised with an aluminium based tetanus toxoid.
The Veterinary record    July 20, 1974   Volume 95, Issue 3 62-63 doi: 10.1136/vr.95.3.62
Scarnell J.No abstract available
Comparison of SN and HI antibody dose response curves in chickens, rabbits, foals and horses following vaccination with equine influenza vaccine.
Journal of biological standardization    April 1, 1974   Volume 2, Issue 2 129-137 doi: 10.1016/0092-1157(74)90027-4
Stellmann C, Petermann HG.After vaccination of chickens, rabbits, foals and horses, HI and SN antibody dose response curves were compared for A/Equi 1/Prague and A/Equi 2/Paris strains. The two curves are parallel for a given strain and the relationship of HI and SN titres is constant, whatever the animal species. The distribution of HI and SN titres varies for the two strains. This variation, which is independent of animal species, may be related to the number of sites necessary for the antigenic-antibody response in vitro. It is suggested that the testing of equine influenza vaccine be carried out in the ...
Letter: Current practice in tetanus prophylaxis.
British medical journal    March 2, 1974   Volume 1, Issue 5904 389 doi: 10.1136/bmj.1.5904.389-a
Caro D, Shaw E.No abstract available
Venezuelan equine encephalitis.
Advances in veterinary science and comparative medicine    January 1, 1974   Volume 18 79-116 
Johnson KM, Martin DH.No abstract available
Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to Eastern or Western Equine encephalitis virus, or both.
Applied microbiology    October 1, 1973   Volume 26, Issue 4 485-488 doi: 10.1128/am.26.4.485-488.1973
Calisher CH, Sasso DR, Sather GE.During 1971, an epizootic of Venezuelan equine encephalitis (VEE) reached the United States. Laboratory tests were performed on a large number of sick, healthy, unvaccinated, and vaccinated horses. Neutralization (N) tests in cell cultures revealed that 153 of 193 (79.3%) equines outside the state of Texas and 175 of 204 (85.8%) within Texas (82.6% overall) had detectable N antibody to VEE virus a week or more after vaccination. Twenty-six of 40 (65%) non-Texas equines and 18 of 29 (62%) Texas equines which had no detectable antibody against VEE virus a week or more after vaccination had N ant...
Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
Modern veterinary practice    August 1, 1973   Volume 54, Issue 8 19-22 
Sampson GR, Elliston NG, Miyat JA, Grueter HP, Gillespie JR, Rathmacher RP.No abstract available
[Experience in the preparation and use of inactivated antigens from influenza viruses of different origins].
Voprosy virusologii    July 1, 1973   Volume 18, Issue 4 489-493 
Isachenko VA, Sokolova NN, Shestochenko MA, Zakstel'skaia LIa.No abstract available
[Immunization of foals against tetanus toxin. II. Transmission of tetanus antibodies with the colostrum to newborn foal and subsequent active immunization].
Archiv fur experimentelle Veterinarmedizin    January 1, 1973   Volume 27, Issue 2 245-250 
Schützler H.No abstract available
Duration of immunity of horses vaccinated with strain TC-83 Venezuelan equine encephalomyelitis virus vaccine. Walton TE, Luedke AJ, Jochim MM, Crenshaw GL, Ferguson JA.No abstract available
Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses.
Journal of the American Veterinary Medical Association    October 1, 1972   Volume 161, Issue 7 824-831 
Luedke AJ, Barber TL, Foster NM, Batalla D, Mercado S.No abstract available
Prevention of tetanus.
Journal of the Indian Medical Association    October 1, 1972   Volume 59, Issue 7 294-295 
Sen B.No abstract available
Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
Journal of the American Veterinary Medical Association    October 1, 1972   Volume 161, Issue 7 832-833 
Monlux WS, Luedke AJ, Mercado S, Rosales JC.No abstract available
Japanese encephalitis in horses in Japan.
Equine veterinary journal    July 1, 1972   Volume 4, Issue 3 155-156 doi: 10.1111/j.2042-3306.1972.tb03900.x
Nakamura H.No abstract available
Preparation and evaluation of inactivated Venezuelan equine encephalitis vaccines.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    June 1, 1972   Volume 19, Issue 6 511-517 doi: 10.1111/j.1439-0450.1972.tb00430.x
Mussgay M, Bergold GH, Weiland E, Ueberschär S.No abstract available
Clinical changes in burros and Shetland ponies after vaccination with Venezuelan equine encephalomyelitis vaccine, TC-83.
Veterinary medicine, small animal clinician : VM, SAC    May 1, 1972   Volume 67, Issue 5 505 
Brown DG.No abstract available
[Serological studies following immunization against horse influenza. 3. Reimmunization two years following first vaccination and antibody level during an interval of three years]. Pressler K.No abstract available
Stability of live attenuated Venezuelan equine encephalitis vaccine.
Applied microbiology    March 1, 1972   Volume 23, Issue 3 654-655 doi: 10.1128/am.23.3.654-655.1972
McManus AT, Robinson DM.Reconstituted Venezulean equine encephalitis vaccine was found to retain significant titers of plaque-forming virus after storage at 4 or 22 C for 24 hr.
Serial measurements of serum protein, glycoprotein, and lipoprotein fractions in normal and Venezuelan equine encephalomyelitis-vaccinated ponies and burros.
American journal of veterinary research    February 1, 1972   Volume 33, Issue 2 323-327 
Rollins JB, Shultz TD, Fiser RH.No abstract available
Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Infection and immunity    February 1, 1972   Volume 5, Issue 2 160-163 doi: 10.1128/iai.5.2.160-163.1972
Eddy GA, Martin DH, Reeves WC, Johnson KM.A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The highest level of viremia measured was 7 x 10(3) to 8 x 10(3) plaqueforming units per ml. No adverse reactions to the vaccine were observed in any horses, including 42 pregnant mares and their resulting foals.
Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae.
Journal of the American Veterinary Medical Association    September 15, 1971   Volume 159, Issue 6 731-738 
Spertzel RO, Kahn DE.No abstract available
[Improving the organization of anti-foot-and-mouth disease measures].
Veterinariia    August 1, 1971   Volume 9 44-46 
Alekhin RM, Darda PN.No abstract available
[Active tetanus prevention in the horse and the duration of immunity].
Schweizer Archiv fur Tierheilkunde    July 1, 1970   Volume 112, Issue 7 307-314 
Löhrer J, Radvila P.No abstract available
Preparation of agglutinating antisera and fluorescent-antibody conjugates against Pasteurella tularensis in equines.
Applied microbiology    June 1, 1970   Volume 19, Issue 6 894-897 doi: 10.1128/am.19.6.894-897.1970
Green JH, Bolin RC, Carver RK, Gross H, Pigott N, Harrell WK.The serological response in burros and horses to the viable LVS strain of Pasteurella tularensis was studied. High-titered agglutinating antisera and fluorescent-antibody conjugates were obtained in both groups of animals. Maximum titers were obtained in horses 14 to 21 days after the start of vaccination and in burros 21 to 28 days after the start of vaccination. The use of Woodhour's adjuvants or booster inoculations did not result in increased titers.
Cellular response to equine encephalomyelitis vaccine in skin window of horses.
American journal of veterinary research    January 1, 1970   Volume 31, Issue 1 97-102 
Zarrilli LW, Calhoun ML.No abstract available
Immunization of horses against equine infectious anemia (EIA) with an attenuated EIA virus.
National Institute of Animal Health quarterly    January 1, 1970   Volume 10, Issue 3 113-122 
Kono Y, Kobayashi K, Fukunaga Y.No abstract available
Induction of tolerance in man to horse-IgG.
Lancet (London, England)    November 22, 1969   Volume 2, Issue 7630 1141-1142 doi: 10.1016/s0140-6736(69)90744-2
Brendel W, Land W, Hopf U, Seifert J.No abstract available